Loading clinical trials...
Loading clinical trials...
Hyperemic Efficacy of Intravenous Infusion of Adenosine in Heart Failure With Reduced Ejection Fraction
Conditions
Interventions
Maximal hyperemia with adenosine followed by nicorandil
Maximal hyperemia with nicorandil followed by adenosine
Locations
1
South Korea
Sejong general hospital, 91-121 Sosa 2-Dong, Sosa-Gu
Bucheon-si, Gyeonggi-do, South Korea
Start Date
March 1, 2017
Primary Completion Date
February 28, 2020
Completion Date
February 28, 2020
Last Updated
August 1, 2017
NCT05681702
NCT07057466
NCT07444697
NCT01311323
NCT01524276
NCT06631157
Lead Sponsor
Sejong General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions